LOS ANGELES--(BUSINESS WIRE)--Pearl, the leader in dental AI solutions, today announced that the United States Food and Drug Administration (FDA) has cleared its AI-powered, real-time pathology ...
CMS floats Medicare payment for AI diagnostic software, proposing a new category to standardize reimbursement for algorithm-driven clinical tools.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results